Using text messages to help reduce PTSD symptoms and hazardous drinking
Testing the efficacy of a CBT-enhanced text message intervention to reduce symptom burden in individuals with post-traumatic stress disorder symptoms and co-occurring hazardous drinking
This study is testing a new text messaging program designed to help people with PTSD and drinking problems by providing support and therapy techniques right on their phones, making it easier for them to feel better without needing to see a therapist in person.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10904690 on NIH RePORTER |
What this research studies
This research investigates a new intervention that uses text messaging to help individuals with post-traumatic stress disorder (PTSD) and hazardous drinking. The approach combines cognitive behavioral therapy techniques with the convenience of mobile technology, making it easier for patients to access support without needing to meet in person with a therapist. The study aims to refine this intervention based on previous pilot findings and evaluate its effectiveness in reducing symptoms and improving overall well-being.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who experience symptoms of PTSD and engage in hazardous drinking behaviors.
Not a fit: Patients who do not have PTSD or hazardous drinking issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more accessible and effective treatment option for individuals struggling with PTSD and hazardous drinking.
How similar studies have performed: While there is limited research on text message interventions for the general public, previous studies have shown promise in similar approaches for veterans.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Lindgren, Kristen P — University of Washington
- Study coordinator: Lindgren, Kristen P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.